Results 21 to 30 of about 22,001 (226)
Lupus Anticoagulant Is Associated with Critical Cases and High Mortality in COVID-19: A Literature Review. [PDF]
Tanaffos, 2023 Moafi M +8 more
europepmc +2 more sources
Transmission of lupus anticoagulant by allogeneic stem cell transplantation
Revista Brasileira de Hematologia e Hemoterapia, 2014 Passive transmission of autoimmune diseases by allogeneic stem cell transplantation is rare and is ascribed to passive transfer of memory B-cells from donor to recipient. We hereby report a case of transmission of an asymptomatic lupus anticoagulant from
Mira Romany Massoud +5 more
doaj +1 more source
Experimental Biology and Medicine, 1984 Lupus-like anticoagulant (LLAC) is the term used to identify an acquired inhibitor (1) of blood coagulation, first described by Conley and Hartmann in patients with systemic lupus erythematosus (SLE) (2). A circulating “lupus-like” anticoagulant has been detected in 5-10% of all SLE patients.
N, Perico, F, Pusineri, G, Remuzzi
openaire +2 more sources
Thrombosis Journal, 2006 Background Lupus anticoagulants prolong clotting times in phospholipid-dependent coagulation tests. Lupus Ratio assays are integrated tests for lupus anticoagulants that may be based on APTT, RVVT or dPT clotting times. If a patient is being treated with
Wisløff Finn +3 more
doaj +1 more source
Loss of antiphospholipid antibody positivity post-thrombosis in SLE
Lupus Science and Medicine, 2020 Background/Purpose Loss of positivity of antiphospholipid antibodies has been observed in clinical practice post-thrombosis in patients with SLE with secondary antiphospholipid syndrome (APS). Our study defined the frequency of this loss and the duration
Muznay Khawaja
doaj +1 more source
Arquivos Brasileiros de Cardiologia, 2002 OBJECTIVE: Lupus anticoagulant and anticardiolipin antibodies (aCL) have been associated with thrombosis, recurrent abortion, and thrombocytopenia in patients with systemic lupus erythematosus (SLE), but their relationship with cardiac disease is less ...
Creso Abreu Falcão +4 more
doaj +1 more source
Osteomyelitis and septic arthritis in neonatal lupus erythematosus patients
Journal of Pediatric Surgery Case Reports, 2022 Osteomyelitis in neonates is quite uncommon and often appears without a typical sign. Clinicians' late diagnosis and inappropriate treatment may result in severe sequelae. We report a rare case of osteomyelitis and septic arthritis infant with a mother's
Virany Diana +4 more
doaj +1 more source
Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban
Case Reports in Rheumatology, 2021 Drug-induced lupus is an iatrogenic-induced autoimmune disease with common offending agents well documented in the literature. To our knowledge, there are no prior case reports of drug-induced lupus associated with apixaban or any other direct oral ...
John Yang +3 more
doaj +1 more source
Hepatic venous outflow block in a young patient with Systemic Lupus Erythematosus [PDF]
Journal of Analytical Research in Clinical Medicine, 2015 Introduction: Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a 3 years survival rate of 50%. Several conditions have been implicated as a cause of Budd-Chiari syndrome, including myeloproliferative disorders ...
Ali Ghavidel
doaj +1 more source
A SYSTEMATIC LITERATURE REVIEW OF BUDD-CHIARI SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Hematology, Transfusion and Cell Therapy, 2021 Objective: Antiphospholipid syndrome is associated with multiple and recurrent episodes of arterial and venous thrombosis, thrombocytopenia, spontaneous fetal losses, and high levels of antiphospholipid antibodies. These antibodies can also be present in
TL Correa +3 more
doaj +1 more source